Corrigendum to "Dually modified transmembrane proteoglycans in development and disease" [Cytokine Growth Factor Rev. 39 (2018) 124-136].
Saved in:
| Title: | Corrigendum to "Dually modified transmembrane proteoglycans in development and disease" [Cytokine Growth Factor Rev. 39 (2018) 124-136]. |
|---|---|
| Authors: | Jenkins LM; Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA., Horst B; Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA., Lancaster CL; Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA., Mythreye K; Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA; Department of Drug Discovery and Biomedical Sciences, South Carolina College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA. Electronic address: Mythreye@sc.edu. |
| Source: | Cytokine & growth factor reviews [Cytokine Growth Factor Rev] 2022 Oct; Vol. 67, pp. 105. Date of Electronic Publication: 2022 Aug 22. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Elsevier Science Country of Publication: England NLM ID: 9612306 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0305 (Electronic) Linking ISSN: 13596101 NLM ISO Abbreviation: Cytokine Growth Factor Rev Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
